[1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25 (11), 1271-1277.10.1002/art.1780251101]Search in Google Scholar
[2. Miyakis S, Lockshin M.D, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Hemost, 2006, 4 (2), 295-306.10.1111/j.1538-7836.2006.01753.x]Search in Google Scholar
[3. Castro-Marrero J, Balada E, Vilardell-Tarrés M, Ordi-Ros J. Genetic risk factors of thrombosis in the antiphospholipid syndrome. Br J Haematol, 2009, 147 (3), 289-296.10.1111/j.1365-2141.2009.07831.x]Search in Google Scholar
[4. Kapitany A, Tarr T, Gytvai A, et al. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome. Ann NY Acad Sci, 2009, 1173, 545-551.10.1111/j.1749-6632.2009.04642.x]Search in Google Scholar
[5. Trabace S, Nicotra M, Cappellacci S, et al. of HLA-DR and DQ antigens and anticardiolipin antibodies in women with recurrent spontaneous abortions. Am J Reprod Immunol, 1991, 26 (4), 147-149.10.1111/j.1600-0897.1991.tb00715.x]Search in Google Scholar
[6. Camps MT, Cuadrado MJ, Ocon P, et al. Association between HLA class II antigens and primary antiphospholipid syndrome from the South of Spain. Lupus, 1995, 4 (1),51-55.10.1177/096120339500400111]Search in Google Scholar
[7. Goldstein R, Moulds JM, Smith CD, Sengar DP. MHS studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol, 1996, 23 (7), 1173-1179.]Search in Google Scholar
[8. Asherson RA, Doherty DG, Vergani D, et al. Concise communication: major histocompatibility complex associations with primary antiphospholipid syndrome. Arthr Theum, 1992, 35 (1),124-125.10.1002/art.1780350119]Search in Google Scholar
[9. Arnett FC, Olsen ML, Anderson L, Reveille JD. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest, 1991, 87 (5), 1490-1495.10.1172/JCI115158]Search in Google Scholar
[10. Arnett FC, Thiagarajan P, Ahn C, Reveille JD. Association of anti-B2 – glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthr Rheum, 1999, 42 (2), 268-274.10.1002/1529-0131(199902)42:2<268::AID-ANR8>3.0.CO;2-K]Search in Google Scholar
[11. Caliz R, Atsumi T, Kondeatis E, et al. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology, 2001, 40 (1), 31-36.10.1093/rheumatology/40.1.31]Search in Google Scholar
[12. Sebastiani D, Minisola G, Galeazzi M. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Autoimmune Rev, 2003, 2 (6), 387-394.10.1016/S1568-9972(03)00068-5]Search in Google Scholar
[13. Granados J, Vargas-Alarcon G, Drenkard C, et al. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA DR7 in Mexican patients with systemic lupus erythematosus (SLE). Lupus, 1997, 6 (1), 57-62.10.1177/096120339700600108]Search in Google Scholar
[14. Davies ML, Young SP, Welsh K, et al. Immune response to native B2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome. Rheumatology, 2002, 41 (4), 395-400.10.1093/rheumatology/41.4.395]Search in Google Scholar
[15. Christiansen OB, Ulcova-Gallova Z, Mohapeloa H, Krauz V. Studies on associations between human leukocyte antigen (HLA) class II alleles and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages. Human Reproduction 1998, 123 (12), 3326-3331.10.1093/humrep/13.12.3326]Search in Google Scholar
[16. Joannidis JPA, Tektonidou MG, Vlachoyiannopoulos PG et al. HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. Hum Immunol, 1999, 60 (12), 1274-1280.10.1016/S0198-8859(99)00122-6]Search in Google Scholar
[17. Freitas MV, da Silva LM, Deghaide NH, et al. Is HLA II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome? Lupus, 2004, 13 (2), 125-131.10.1191/0961203304lu520oa14995006]Search in Google Scholar
[18. Galeazzi M, Sebastiani GD, Tincani A, et al. HLA class II associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus, 2000, 9 (1),47-55.10.1177/09612033000090010910715100]Search in Google Scholar
[19. Marintchev L, Naumova E, Rashkov R, et al. HLA class II alleles and autoantibodies in Bulgarians with systemic lupus erythematosus. Tissue Antigens, 1995, 46 (5), 422-425.10.1111/j.1399-0039.1995.tb03141.x8838358]Search in Google Scholar
[20. Sebastiani D, Iuliano A,Cantarini L, Galeazzi M. Genetic aspects of antiphospholipid syndrome. An update. Autoimmune Rev, 2016, 15 (5), 433-43910.1016/j.autrev.2016.01.00526804759]Search in Google Scholar
[21. Uthman I, Khamashta M. Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis 2005, 64 (12), 1671-1676.10.1136/ard.2005.038448175532615919676]Search in Google Scholar